These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22127196)

  • 1. Can pindolol really enhance antidepressant effect?
    Terao T
    J Clin Psychiatry; 2011 Nov; 72(11):1558; author reply 1558. PubMed ID: 22127196
    [No Abstract]   [Full Text] [Related]  

  • 2. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.
    Portella MJ; de Diego-Adeliño J; Ballesteros J; Puigdemont D; Oller S; Santos B; Álvarez E; Artigas F; Pérez V
    J Clin Psychiatry; 2011 Jul; 72(7):962-9. PubMed ID: 21034693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitchell B. Balter Award--1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients.
    Räsänen P; Hakko H; Tiihonen J
    J Clin Psychopharmacol; 1999 Aug; 19(4):297-302. PubMed ID: 10440455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pindolol potentiates the panicolytic effect of paroxetine in the elevated T-maze.
    Sela VR; Roncon CM; Zangrossi H; Graeff FG; Audi EA
    Life Sci; 2010 Sep; 87(13-14):445-50. PubMed ID: 20816996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.
    Perry EB; Berman RM; Sanacora G; Anand A; Lynch-Colonese K; Charney DS
    J Clin Psychiatry; 2004 Feb; 65(2):238-43. PubMed ID: 15003079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unfavorable smell with citalopram?
    Ghanizadeh A
    J Clin Psychopharmacol; 2007 Oct; 27(5):528-9. PubMed ID: 17873697
    [No Abstract]   [Full Text] [Related]  

  • 7. Pindolol augmentation of tranylcypromine in psychotic depression.
    Kraus RP
    J Clin Psychopharmacol; 1997 Jun; 17(3):225-6. PubMed ID: 9169970
    [No Abstract]   [Full Text] [Related]  

  • 8. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
    Bakish D; Hooper CL; Thornton MD; Wiens A; Miller CA; Thibaudeau CA
    Int Clin Psychopharmacol; 1997 Mar; 12(2):91-7. PubMed ID: 9219044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of age-of-onset of antidepressant use on the acute CBF response to a citalopram challenge; a pharmacological MRI study.
    Solleveld MM; Schrantee A; Homberg JR; Lucassen PJ; Reneman L
    Psychiatry Res Neuroimaging; 2020 Sep; 303():111126. PubMed ID: 32592855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First time, low dose citalopram use-related serotonin syndrome.
    Turedi S; Eraydin I; Gunduz A; Kalkan A; Hos U
    Neurotoxicology; 2007 Nov; 28(6):1272-4. PubMed ID: 18213744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
    Maes M; Vandoolaeghe E; Desnyder R
    J Affect Disord; 1996 Dec; 41(3):201-10. PubMed ID: 8988452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
    Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
    J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression.
    Segrave R; Nathan PJ
    Hum Psychopharmacol; 2005 Apr; 20(3):163-74. PubMed ID: 15648095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial.
    Zhou J; Wang W; Yang J; Zhu X; Feng L; Xiao L; Wang G
    Trials; 2019 Jan; 20(1):33. PubMed ID: 30626409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM; Brown EB; Gonzales JS; Munir R
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calming Alzheimer's agitation: a promising drug.
    Johns Hopkins Med Lett Health After 50; 2014 Jun; 29(5):8. PubMed ID: 25097959
    [No Abstract]   [Full Text] [Related]  

  • 17. Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder.
    Fontenelle LF; Mendlowicz MV; Miguel EC; Versiani M
    World J Biol Psychiatry; 2005; 6(1):57-9. PubMed ID: 16097406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tapping the potential of isomer science.
    Enos G
    Behav Healthc Tomorrow; 2002 Feb; 11(1):SR30-1. PubMed ID: 11837139
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral disinhibition without persistent mood elevation after high dose citalopram treatment.
    Rocha FF; Correa H; Lage NV
    Braz J Psychiatry; 2007 Dec; 29(4):384-5. PubMed ID: 18200405
    [No Abstract]   [Full Text] [Related]  

  • 20. Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.
    Wade AG; Crawford GM; Nemeroff CB; Schatzberg AF; Schlaepfer T; McConnachie A; Haazen L; Buntinx E
    Psychol Med; 2011 Oct; 41(10):2089-97. PubMed ID: 21349239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.